Cargando…

Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy

Background: Chemotherapy is the basic treatment for colorectal cancer (CRC). However, colorectal cancer cells often develop resistance to chemotherapy drugs, leading to recurrence and poor prognosis. More and more studies have shown that the Homologous recombination (HR) pathway plays an important r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yan, Liao, Xiaoli, Zhang, Yumei, Wu, Guobin, Ye, Jiazhou, Luo, Shanshan, He, Xinxin, Luo, Min, Xie, Mingzhi, Zhang, Jinyan, Li, Qian, Huang, Yu, Liao, Sina, Li, Yongqiang, Liang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207269/ https://www.ncbi.nlm.nih.gov/pubmed/35734400 http://dx.doi.org/10.3389/fphar.2022.920939

Ejemplares similares

Progress of research on molecular targeted therapies for colorectal cancer
por: Huang, Shilin, et al.
Publicado: (2023)

Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis
por: Luo, Dongcheng, et al.
Publicado: (2022)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019)

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2022)

Recombinant Ganoderma lucidum Immunomodulatory Protein Improves the Treatment for Chemotherapy-Induced Neutropenia
por: Lei, Xinhua, et al.
Publicado: (2020)

Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1)
por: Luo, Dongcheng, et al.
Publicado: (2022)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy
por: Qi, Wenqian, et al.
Publicado: (2023)

mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis
por: Zhang, Yumei, et al.
Publicado: (2022)

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
por: Liu, Jia-Si, et al.
Publicado: (2023)

Clinical efficacy and safety of apatinib in patients with advanced colorectal cancer as the late-line treatment
por: Liao, Xiaoli, et al.
Publicado: (2018)

Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective
por: Cheng, Xiao L., et al.
Publicado: (2015)

Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy
por: Li, Yunyue, et al.
Publicado: (2023)

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer
por: Luo, Cong, et al.
Publicado: (2022)

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System
por: Zhang, Haofuzi, et al.
Publicado: (2021)

Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte–Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study
por: Wu, Qiuji, et al.
Publicado: (2021)

Long non-coding RNA-based risk scoring system predicts prognosis of alcohol-related hepatocellular carcinoma
por: Luo, Yue, et al.
Publicado: (2020)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

Integrating machine learning to construct aberrant alternative splicing event related classifiers to predict prognosis and immunotherapy response in patients with hepatocellular carcinoma
por: Liu, Wangrui, et al.
Publicado: (2022)

A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
por: Li, Haiyan, et al.
Publicado: (2023)

Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses
por: Fang, Kun, et al.
Publicado: (2022)

The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Zou, Ting, et al.
Publicado: (2020)

Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma
por: Xie, Mingzhi, et al.
Publicado: (2018)

Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma
por: Xia, Qin-Xuan, et al.
Publicado: (2022)

Explore the Usefulness of Concurrent Chemotherapy in Stage II Nasopharyngeal Carcinoma: A Retrospective Study
por: Li, Pei-Jing, et al.
Publicado: (2021)

Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapy
por: Zhou, Qin, et al.
Publicado: (2023)

Chemotherapy Combined With Immunotherapy as a First-Line Treatment Brings Benefits to Patients With Lung Squamous Cell Carcinoma but Different Risks of Adverse Reactions: A Systematic Review and Meta-Analysis
por: Chen, Qian, et al.
Publicado: (2022)

The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease
por: Shu, Huapan, et al.
Publicado: (2023)

Recombinant Annexin A2 Administration Improves Neurological Outcomes After Traumatic Brain Injury in Mice
por: Cheng, Chongjie, et al.
Publicado: (2021)

Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
por: Lin, Anqi, et al.
Publicado: (2021)

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

Fabrication of pH/Redox Dual-Responsive Mixed Polyprodrug Micelles for Improving Cancer Chemotherapy
por: Luo, Ji, et al.
Publicado: (2022)

Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study
por: Jiang, Zhouhong, et al.
Publicado: (2022)

Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus
por: Li, Xiaoli, et al.
Publicado: (2023)

A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients
por: Chen, Songming, et al.
Publicado: (2021)

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma
por: Sun, Yuming, et al.
Publicado: (2023)

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
por: Qiu, Qin, et al.
Publicado: (2020)

Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer
por: Liao, Gaoming, et al.
Publicado: (2021)

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels
por: Udoh, Michael, et al.
Publicado: (2022)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
por: Niu, Yuchun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rl21osq39co9hmjup8v0hr06to